Clinical Trial Update: TGRX-678 Chinese Phase I in Chronic Myelogenous Leukemia (CML) Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for TGRX-678 in Chinese patients with chronic myeloid leukemia; trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• TGRX-678

Snippet

Sponsor: Shenzhen TargetRx Co., Ltd. | Conditions: Chronic Myelogenous Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING